Driving a Culture of Innovation and Entrepreneurship at Rutgers through technology transfer.
Looking for an invention or technology to commercialize? Explore our portfolio of technologies available for licensing.
Email us at marketingbd@research.rutgers.edu for questions and partnership opportunities.
Staffed by scientists and IP experts with industry experience, the Office for Research is dedicated to transforming research at Rutgers into products, services, and partnerships for the public good, generating value for the University and New Jersey. We do this through technology transfer, guiding your research from proof of concept through patenting, licensing, and commercialization, while also evaluating the potential for a startup as a vehicle to bring your innovations to the market. If a startup option is selected, we will assist you with the planning and development that lead to a spin-out of your innovation. We will also provide mentoring, access to early-stage seed funding, support in obtaining dilutive/non-dilutive funding, assistance with product and business development, and connection to industry and potential business founders.
To access your account, please select the appropriate option below.
Tech Transfer's purpose is to partner with the Rutgers community to encourage deliberate innovation, protect and leverage Rutgers intellectual property, foster collaboration with industry, and enable entrepreneurship.
Fiscal Year 2023
Fiscal Year 2023
Fiscal Year 2023
Fiscal Year 2023
This webinar explores non-dilutive funding, a financing option that allows innovators to maximize their equity or ownership, as well as the resources Technology Transfer provides, from founders and researchers who have launched startups and successfully secured non-dilutive funding.
This webinar highlights how our team works with innovators to decide between launching a startup and licensing to an existing company, why a startup may be the right choice, what does it mean to be a founder of a startup and the available resources at Technology Transfer to help along the way (NetID required to view video).
This webinar focuses on how industry partners evaluate research collaborations and technology licensing opportunities: the type of data they look for, how to speak their language and what questions to expect.
In this webinar, hear from prolific faculty researchers about how they developed their technologies, engaged with Technology Transfer, secured commercialization focused funding, and attracted industry interest to advance the commercialization of their innovative ideas.
Rutgers startup Zena Therapeutics strives to create narcotic medications that will minimize or even eliminate overdoses from prescription drugs.
Key findings in the report highlight the persistence of disparities in tobacco use by race and ethnicity, level of income, level of education, gender identity, type of occupation, geography, and behavioral health status.
Rutgers Health study uncovers vulnerabilities in drug-resistant TB, offering hope for improved treatments.
The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to Rutgers Health researchers.
Obesity causes insulin resistance by increasing activation of the sympathetic nervous system and the release of the stress hormone norepinephrine, according to a Rutgers Health study.
The findings, published in the journal Vaccine, shed light on disparities in vaccine uptake within this diverse population.
U.S. Air Force officials installed a new kind of structure in the waters of St. Andrew Bay on the shore of the Tyndall U.S. Air Force Base in northwest Florida– the first section of a Rutgers University-designed “self-healing” reef made of custom-designed concrete modules and living oysters.
The Clinical and Translational Science Award (CTSA), the state’s only CTSA, transforms research discoveries into practical treatments, and is funded through the New Jersey Alliance for Clinical and Translational Science (NJ ACTS).
